The NPC1L1 Gene Exerts a Notable Impact on the Reduction of Low-Density Lipoprotein Cholesterol in Response to Hyzetimibe: A Factorial-Designed Clinical Trial - Liao, Jianwei; Yang, Liyun; Zhou, Luping; Zhao, Hongbin; Qi, Xiao; Cui, Yimin; Ouyang, Dongsheng (Frontiers in pharmacology, 2022)
Keywords: ezetimibe; factorial design; hyzetimibe; NPC1L1 gene; Pharmacology; precise treatment; SNP; hyzetimibe; factorial design; precise treatment; SNP; ezetimibe; NPC1L1 gene